retatrutide approval vs Tirzepatide vs Semaglutide Retatrutide for weight loss: Study

the drugs work by modulating appetite, regulating blood sugar, and slowing gastric emptying

On average both groups used 2.6 (SD 1.2 and 1.1) anti-diabetes medication classes and 73.6% and 74.9% of patients used insulin during the baseline period in the GLP1-RA and DPP4i groups, respectively

Colorectal Neoplasms In SAXENDA clinical trials in adults, benign colorectal neoplasms (mostly colon adenomas) confirmed by adjudication were reported in 20 (0.6%) of 3,291 SAXENDA-treated patients compared with 7 (0.4%) of 1,843 placebo-treated patients

These findings underscore that GLP-1 therapy is a long-term intervention rather than a short-term solution